Read about the wide variation in resource use differences between #MedicareAdvantage and traditional #Medicare in a new paper published this month from JeahJung of George Mason University + coauthors. bit.ly/464zH18

Coverage of our recent The BMJ study in HealthDay News news: physiciansweekly.com/industry-payme…

Did you know hospitalization and ER visit rates differ quite a bit among home- and community-based service vs nursing facility service users, depending on where you live? For more information, read our paper: journals.sagepub.com/doi/10.1177/10… #LTC #aging #Medicaid

Pharmacy Benefit Managers (#PBM): How did they emerge? What do they do? How should we evaluate policy proposals that regulate them? Ge Bai, David Hyman, & I discuss in JAMA Health Forum (Thread 12/12) jamanetwork.com/journals/jama-…

Future oncology health services researchers - Great new opportunity for protected research time while working at the world's greatest cancer center! Put this post-doc at Memorial Sloan Kettering Cancer Center on your radar!

A holiday season publication! We find that infliximab and filgrastim biosimilar uptake from 2017-2019 is consistently higher in MA compared to TM, and that Kaiser HMO plans drive those differences. Mariana Socal Kelly Anderson, Andrew Xuan, & Jerry Anderson jmcp.org/doi/full/10.18…

How much money does #Medicare waste each year on guideline-discordant bone therapy for prostate cancer? Our answer, reported this week in JCO Oncology Practice: $43 million per year Even in the health care world, that ain't pocket change. ascopubs.org/doi/10.1200/OP… 🧵 1/

Excited to host Michael Anne Kyle at Memorial Sloan Kettering Cancer Center! Discussing this recent work on prior authorization, subject of my quoted tweet below. (MSK peeps who want to attend in person, email me!)

How do Medicare outcomes differ among racial and ethnic groups? @JeanKJung of George Mason University +coauthors explore differences in quality-of-care outcomes in Medicare and MA between minority and non-Hispanic White populations. Read the full study: bit.ly/4cp27Xo

I'm really looking forward to this talk! Signup in the linked tweet. (east coasters, note the GMT time zone!) Anna Kaltenboeck @TimAndersonMD Audrey D. Zhang Dan hartung Colleen Carey Kosuke Inoue Yusuke Tsugawa Jing Li 李婧 JeahJung Stacie Dusetzina Genevieve Kanter, PhD

Looking forward to presenting our new findings at #ASCO24! How much industry money do NCI cancer centers receive, relative to public/NCI funding? 🤔

Looking forward to presenting findings on differences in cancer treatment between Medicare Advantage and Medicare FFS patients, with JeahJung & co on the team! #ASCO24

New in JAMA Psychiatry with Emmanuel Greenberg, Susan Busch Marissa King jamanetwork.com/journals/jamap… We meticulously identified 1800+ private equity-owned outpatient mental health and substance use treatment clinics from 2012-2023.

Looking forward to presenting this collaborative work with JeahJung &co at #ASCO24! We compared resource use (dollars spent) on cancer treatment between traditional Medicare and Medicare Advantage... meetings.asco.org/abstracts-pres…

...and found that Medicare Advantage appears more efficient, spending substantially less over a 6-month treatment episode. Differences driven by both lower intensity (fewer treatment days) and use of less-expensive drugs.

Thanks pharmalot STAT for your interest in our study! Published today in JAMA: statnews.com/pharmalot/2024…

New in HSR: "Requiem for Odds Ratios" with Bryan Dowd, Melissa Garrido, and Matt Maciejewski. onlinelibrary.wiley.com/toc/14756773/0… We commend HSR for discouraging the reporting of odds ratios in most studies. We agree wholeheartedly with this decision, which keeps HSR at the forefront.

Our new findings out in JAMA Network Open this week - we find lower service utilization among cancer patients covered by Medicare Advantage vs. FFS Medicare: jamanetwork.com/journals/jaman…

Notably, we saw no decrease in quality measures, including overall survival. Thanks to JeahJung for inviting me to collaborate on this important work! More to come soon...

And thank you to Michael Anne Kyle and @NancyKeatingMD for their comments: jamanetwork.com/journals/jaman…